ABBV 1Q20 results—HCV sales=$564M, -10.8% QoQ: https://investors.abbvie.com/news-releases/news-release-details/abbvie-reports-first-quarter-2020-financial-results No change in ABBV's 2020 (non-GAAP) EPS guidance. AGN acquisition still slated for closing in May 2020.